The Boston Examiner
SEE OTHER BRANDS

The most trusted news from Massachusetts

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on July 29, 2025

New Imprivata Report: Hospitals Save an Average of $1.1M Annually with Shared Mobile Devices, But Most Still Lack a Formal Use Policy

New Imprivata Report: Hospitals Save an Average of $1.1M Annually with Shared Mobile Devices, But Most Still Lack a Formal Use Policy

WALTHAM, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of access management solutions for healthcare and other mission-critical industries, today released new global research revealing that 92% of healthcare leaders now consider …

Smarter Hiring Starts Here: Employ’s New AI Release Prioritizes Recruiter Efficiency and Human Connection

Smarter Hiring Starts Here: Employ’s New AI Release Prioritizes Recruiter Efficiency and Human Connection

DENVER, July 29, 2025 (GLOBE NEWSWIRE) -- Employ unveiled a powerful wave of product innovations designed to transform how organizations attract, engage and hire top talent across two of its industry-leading applicant tracking systems – Lever and Jobvite. …

Liberty Announces Closing of Listed Issuer Financing Exemption (LIFE) Private Placement of Units

Liberty Announces Closing of Listed Issuer Financing Exemption (LIFE) Private Placement of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR DISSEMINATION IN THE UNITED STATES WILMINGTON, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FRANKFURT: E30), a leading technology …

Lakeside Software Appoints Daniel Salinas as Chief Operating Officer, Strengthening Leadership in DEX and DEM Innovation

Lakeside Software Appoints Daniel Salinas as Chief Operating Officer, Strengthening Leadership in DEX and DEM Innovation

BOSTON, July 29, 2025 (GLOBE NEWSWIRE) -- Lakeside Software, the first AI-driven digital employee experience (DEX) company, today announced the appointment of Daniel Salinas as Chief Operating Officer. In his new role, Salinas will oversee Sales, Customer …

Cerence AI Brings State-of-the-Art Voice Interaction to LG TVs with Human-Like Neural Text-to-Speech

Cerence AI Brings State-of-the-Art Voice Interaction to LG TVs with Human-Like Neural Text-to-Speech

BURLINGTON, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that LG Electronics Inc. is leveraging Cerence’s cloud neural text-to- …

V2 Communications Accelerates Growth with Bold New Client Wins and Standout Industry Events

V2 Communications Accelerates Growth with Bold New Client Wins and Standout Industry Events

BOSTON, July 29, 2025 (GLOBE NEWSWIRE) -- Integrated communications firm V2 Communications (V2) today announced a slate of new client partnerships spanning its core B2B, climate and healthcare practices, maintaining momentum following wins earlier this …

Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results

Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results

BOSTON, July 29, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …

Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

Revenue of $182 million, year-over-year increase of 15% as reported and 17% organic non-COVID growth Orders grew sequentially and greater than 20% year-over-year Increasing revenue guidance to range of $715 to $735 million, which represents 12.5% -15.5% …

uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

~ Achieved alignment with the FDA on the AMT-130 statistical analysis plan and CMC requirements to support a planned BLA submission in the first quarter of 2026; ~ Company expects to present AMT-130 topline three-year data in September 2025 ~ ~ Presented …

EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration

EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration

– LUCIA pivotal Phase 3 trial enrolled and randomized over 400 patients in seven months, demonstrating continued strong enthusiasm for the DURAVYU pivotal program across the global retinal community – – Over 800 patients enrolled across the LUGANO and …

Ocular Therapeutix™ to Report Second Quarter 2025 Financial Results on August 5, 2025

Ocular Therapeutix™ to Report Second Quarter 2025 Financial Results on August 5, 2025

BEDFORD, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it plans to host a conference call and webcast on Tuesday, …

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025

― Announced results from the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD); pociredir was generally well-tolerated with no treatment-related serious adverse events (SAEs) ― ― Observed robust and rapid pan- …

Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the  Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

― Robust and clinically meaningful absolute mean fetal hemoglobin (HbF) induction of 8.6% from baseline at 12 weeks of treatment; 7 of 16 patients achieved absolute HbF levels greater than 20% ― ― Evidence of pan-cellular induction of HbF based on an …

Lumina Datamatics Commemorates 50 Years of Excellence with the Annual Achievers Awards 2025 at Jio World Convention Centre in Mumbai

Lumina Datamatics Commemorates 50 Years of Excellence with the Annual Achievers Awards 2025 at Jio World Convention Centre in Mumbai

MUMBAI, India, July 29, 2025 (GLOBE NEWSWIRE) -- The Datamatics Group hosted its 50-Year Golden Jubilee on July 18, 2025, with the Annual Achievers Awards (AAA) 2025 at the iconic Jio World Convention Centre, Mumbai. The theme for the event was “Innovative …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions